Prevail Therapeutics is a biotechnology business based in the US. Prevail Therapeutics shares (PRVL) are listed on the NASDAQ and all prices are listed in US Dollars. Prevail Therapeutics employs 66 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Prevail Therapeutics stock
How to buy Prevail Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PRVL. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Prevail Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Prevail Therapeutics stock price (NASDAQ: PRVL)
Use our graph to track the performance of PRVL stocks over time.Prevail Therapeutics shares at a glance
52-week range | $0.00 - $0.00 |
---|---|
50-day moving average | $23.03 |
200-day moving average | $13.95 |
Wall St. target price | $23.63 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-7.80 |
Is it a good time to buy Prevail Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Prevail Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -29.11% |
Return on equity TTM | -52.34% |
Profit margin | 0% |
Book value | $5.34 |
Market Capitalization | $787.7 million |
TTM: trailing 12 months
Prevail Therapeutics share dividends
We're not expecting Prevail Therapeutics to pay a dividend over the next 12 months.
Prevail Therapeutics overview
Prevail Therapeutics Inc. , a gene therapy company, focuses on developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. The company's lead product candidate is PR001, which is in Phase I/II clinical trial for the treatment of Parkinson's disease with GBA1 mutation and neuronopathic Gaucher disease. It is also developing PR006 for the treatment of frontotemporal dementia with GRN mutation; and PR004 for the treatment of synucleinopathies. Prevail Therapeutics Inc. was founded in 2017 and is based in New York, New York. .
Frequently asked questions
What percentage of Prevail Therapeutics is owned by insiders or institutions?Currently 13.001% of Prevail Therapeutics shares are held by insiders and 92.416% by institutions. How many people work for Prevail Therapeutics?
Latest data suggests 66 work at Prevail Therapeutics. When does the fiscal year end for Prevail Therapeutics?
Prevail Therapeutics's fiscal year ends in December. Where is Prevail Therapeutics based?
Prevail Therapeutics's address is: 430 East 29th Street, New York, NY, United States, 10016 What is Prevail Therapeutics's ISIN number?
Prevail Therapeutics's international securities identification number is: US74140Y1010 What is Prevail Therapeutics's CUSIP number?
Prevail Therapeutics's Committee on Uniform Securities Identification Procedures number is: 74140Y101
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question